December 9, 2024

Polygon at the CVCT Forum 2024 in Washington D.C.

Polygon Therapeutics is proud to announce that founder and Chief Scientific Officer, Prof. Hafid Ait-Oufella, attended the Cardiovascular Clinical Trialists Forum (CVCT) in Washington, D.C., for the second consecutive year.
This prestigious international event gathers clinical trialists, researchers, industry leaders, and regulatory experts to explore the latest challenges and advancements in cardiovascular clinical trials. As Polygon prepares for its clinical phases, this forum provided a unique opportunity to engage with global experts and present our vision for the future of cardiovascular research.
A heartfelt thank you to the CVCT community for the enriching discussions and valuable insights that will help shape the next steps of our innovative therapeutic strategy.

Let's unite